Skip to main content
Clinical Trials/NCT04828902
NCT04828902
Unknown
Not Applicable

Incidence of Postoperative Delirium After Cardiac Surgery in Adults - a Prospective Observational Cohort Study

Medical University of Gdansk1 site in 1 country600 target enrollmentFebruary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Delirium
Sponsor
Medical University of Gdansk
Enrollment
600
Locations
1
Primary Endpoint
Delirium incidence and risk
Last Updated
5 years ago

Overview

Brief Summary

Postoperative delirium is an acute syndrome of mental deterioration characterized by acute onset and fluctuating course during the day. Very frequent delirium is a presage of other serious comorbidities i.e.: sepsis, acute kidney injury, circulatory and/or respiratory failure. A detailed knowledge of symptoms and early diagnose of delirium increase the chances of early therapy. To what extent the occurrence of postoperative delirium influences hospital therapy in the Cardiac Surgical Postoperative ICU in University Clinical Centre in Gdańsk is unknown so far.

Detailed Description

Study type: prospective, observational cohort study. Facility: tertiary, university hospital Methods: Patients will undergo routine, continuous observation for symptoms of delirium by a trained nursing staff. Occurrence of delirium, Delirium Observation Screening Scale (DOSS) grading, and therapy will by annotated on case record forms (CRFs) every 12 hours. Additionally, collected will be known risk factors of delirium: schedule type, age, arterial hypertension, atrial fibrillation, body mass index (BMI), angiotensin converting enzyme (ACE) inhibitors / angiotensin receptor blockers (ARBs) therapy, hearing loss, dementia, peripheral artery disease, myocardial infarction, depression, diabetes, corona virus disease 2019 (COVID19) infection and/or vaccination; and outcome data: hospital-LOS, prolonged sedation, antipsychotic therapy, surgical reintervention, hours on mechanical ventilation (HOV), number of tracheal intubations, length of consciousness disorders, blood product transfusions, cardiopulmonary resuscitation (CPR), renal replacement therapy (RRT), mechanical circulatory support (MCS), duration of catecholamine support, ICU readmissions, new antibiotic therapies, 30-day mortality. Statistical methods: Delirium morbidity and risk will be calculated from two-by-two table. Associations between delirium and secondary outcome measures will be evaluated by simple and logistic regression with use of ANOVA test for continuous variables with homogeneous distribution, or Kruskal-Wallis test for continuous variables with non-homogeneous distribution, or categorical variables. Significant will be considered results with p\<0.05. A period of one year was assumed sufficient to draw conclusions on the primary endpoints of the study.

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
August 31, 2022
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maciej M. Kowalik, MD, PhD

Promotor, Dr hab. n. med. Maciej Michał Kowalik

Medical University of Gdansk

Eligibility Criteria

Inclusion Criteria

  • Adult patients (\>18 y.a.), undergoing cardiac surgery, who will sign an informed consent to participate in the study.

Exclusion Criteria

  • Deny to sign or absence of an informed consent.

Outcomes

Primary Outcomes

Delirium incidence and risk

Time Frame: Through hospitalisation in Postop-ICU - an average of 2 days

Incidence and risk of postoperative delirium

Risk factors of delirium.

Time Frame: Through hospitalisation in Postop-ICU - an average of 2 days

collected will be known risk factors of delirium: schedule type, age, arterial hypertension, atrial fibrillation, BMI, ACE/ARBs therapy, hearing loss, dementia, peripheral artery disease, myocardial infarction, depression, diabetes, COVID19 and/or vaccination for it; and outcome data: hospital-LOS, prolonged sedation, antipsychotic therapy, surgical reintervention, direct coercion, length of mechanical ventilation, number of tracheal intubations, length of consciousness disorders, blood product transfusions, cardiopulmonary resuscitation, renal replacement therapy, mechanical circulatory support, duration of catecholamine support, ICU readmissions, new antibiotic therapies, 30-day mortality.

Association between delirium and length of stay in ICU (LOS-ICU).

Time Frame: Through hospitalisation in Postop-ICU - an average of 2 days

Association between delirium and length of stay in ICU (LOS-ICU).

Secondary Outcomes

  • DOSS(Through hospitalisation in Postop-ICU - an average of 2 days)
  • Hospital-LOS(Through hospitalisation in Postop-ICU - an average of 2 days)
  • Hours on ventilator.(Through hospitalisation in Postop-ICU - an average of 2 days)
  • Intubations(Through hospitalisation in Postop-ICU - an average of 2 days)
  • Consciousness disorders(Through hospitalisation in Postop-ICU - an average of 2 days)
  • Transfusions(Through hospitalisation in Postop-ICU - an average of 2 days)
  • CPR, RRT, MCS(Through hospitalisation in Postop-ICU - an average of 2 days)
  • Catecholamines(Through hospitalisation in Postop-ICU - an average of 2 days)
  • ICU readmissions(Through hospitalisation in Postop-ICU - an average of 2 days)
  • New antibiotic(Through hospitalisation in Postop-ICU - an average of 2 days)
  • 30-day mortality(30 days after operation)
  • Prolonged sedation, antipsychotic therapy and surgical re-intervention.(Through hospitalisation in Postop-ICU - an average of 2 days)

Study Sites (1)

Loading locations...

Similar Trials